Plain-English translation of NCT03161808 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Cystic Fibrosis research guide →This is a research study that collects cells and blood samples from people with cystic fibrosis who carry rare mutations in their CFTR gene. The researchers are building a collection of these samples to study how rare mutations affect the disease and potentially develop better treatments in the future. No experimental drugs or treatments are involved—this is simply a cell and tissue collection study.
Most cystic fibrosis research focuses on common mutations, leaving people with rare mutations with fewer treatment options and less scientific understanding of their condition. By collecting and studying cells from people with these rare mutations, researchers hope to better understand how different mutations affect the disease and eventually create more personalized treatments.
You likely qualify if…
You likely don't qualify if…
You will travel to UAB for a two-day visit. During this time, researchers will collect blood samples, cells from your intestines (via a small biopsy), and cells from your nasal passage. The study compensates you for your time and covers all travel expenses. There are no ongoing visits or follow-up appointments required after the initial two-day collection.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States